Advocacy intelligence hub — real-time data for patient organizations
International Extranodal Lymphoma Study Group (IELSG)
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Ukoniq
(umbralisib)Orphan drugstandardTG Therapeutics, Inc.
BRUKINSA
(zanubrutinib)Orphan drugacceleratedBeOne Medicines USA, Inc.
Kinase Inhibitor [EPC]
12.1 Mechanism of Action Zanubrutinib is a small-molecule inhibitor of Bruton's tyrosine kinase (BTK). Zanubrutinib forms a covalent bond with a cyste...
Markus Raderer, Prof
Department of Internal Medicine I
David Maloney
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Shuhua Yi, Dr
Institute of Hematology & Blood Diseases Hospital, Chinese
Jun Shi
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Paolo Caimi, MD, M.D
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
📍 CLEVELAND, OH
Thomas G. Martin, MD
University of California, San Francisco